Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

5.6K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oligodendrocyte Piezo2 is a regulator of age-dependent myelin integrity and dysregulated in multiple sclerosis.

Communications biology·2026
Same author

Motherhood choice in multiple sclerosis (MoMS) - Pilot trial of web-based decision support.

PloS one·2026
Same author

Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

The presynaptic protein bassoon is a biofluid biomarker of synaptic pathology in multiple sclerosis.

EBioMedicine·2026
Same author

Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world data.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Development and expert refinement of a stratified framework for progression independent of relapse activity (PIRA) in multiple sclerosis.

Clinical neurology and neurosurgery·2026

Related Experiment Video

Updated: May 28, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.0K

OCT-Based Retina Assessment Reflects Visual Impairment in Multiple Sclerosis.

Natacha Stolowy1,2, Lilija Gutmann3, Margareta Lüpke3

  • 1APHM, Hopital de la Conception, Department of Ophthalmology, Marseille, France.

Investigative Ophthalmology & Visual Science
|February 13, 2025
PubMed
Summary
This summary is machine-generated.

Optical coherence tomography (OCT) reveals retinal thinning in multiple sclerosis (MS) patients. Macular ganglion cell layer (mGCIPL) volume is the best indicator of vision loss and neurodegeneration in MS.

More Related Videos

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
07:08

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats

Published on: January 10, 2019

9.9K
Application of Optical Coherence Tomography to a Mouse Model of Retinopathy
08:22

Application of Optical Coherence Tomography to a Mouse Model of Retinopathy

Published on: January 12, 2022

3.9K

Related Experiment Videos

Last Updated: May 28, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.0K
Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
07:08

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats

Published on: January 10, 2019

9.9K
Application of Optical Coherence Tomography to a Mouse Model of Retinopathy
08:22

Application of Optical Coherence Tomography to a Mouse Model of Retinopathy

Published on: January 12, 2022

3.9K

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Medical Imaging

Background:

  • Multiple Sclerosis (MS) is a demyelinating disease affecting the central nervous system.
  • Visual impairment is common in MS, impacting quality of life.
  • Optical Coherence Tomography (OCT) is a non-invasive imaging technique to assess retinal structure.

Purpose of the Study:

  • To investigate the correlation between visual function and retinal layer thickness in people with MS (PwMS) compared to healthy controls (HC).
  • To evaluate the efficacy of OCT in detecting visual impairment in PwMS.
  • To compare different visual acuity tests and their association with retinal morphology.

Main Methods:

  • Data collected from 137 PwMS and 118 HC at two neurology centers.
  • Neurological, ophthalmological assessments, including OCT, high-contrast visual acuity (HCVA), low-contrast visual acuity (LCVA), and area under the log contrast sensitivity function (AULCSF).
  • Follow-up assessments conducted after one year.

Main Results:

  • PwMS showed reduced peripapillary retinal nerve fiber layer (pRNFL) and macular ganglion cell-inner plexiform layer (mGCIPL) volume compared to HC.
  • Specific cutoffs for pRNFL thickness were associated with visual impairment (HCVA, LCVA, AULCSF).
  • mGCIPL volume was most strongly associated with AULCSF, and AULCSF correlated best with both pRNFL and mGCIPL.

Conclusions:

  • AULCSF is a sensitive measure of visual function, closely mirroring retinal atrophy.
  • mGCIPL loss is a stronger indicator of neurodegeneration and visual impairment than pRNFL, without a cutoff effect.
  • OCT, particularly mGCIPL measurement, is a valuable tool for assessing neuronal atrophy in MS.